BioCentury | Feb 15, 2016
Company News

Shionogi, Nissan Chemical deal

...toxicity. The companies did not respond to inquiries. Shionogi & Co. Ltd. (Tokyo:4507), Osaka, Japan Nissan Chemical Industries Ltd....
BioCentury | Aug 23, 2010
Clinical News

Livalo pitavastatin regulatory update

...reference member state. Kowa said pitavastatin has also been approved in the Netherlands. Kowa and Nissan Chemical Industries Ltd....
BioCentury | Jul 26, 2010
Clinical News

Livalo pitavastatin regulatory update

...the reference member state. The product is expected to be launched next year. Kowa and Nissan Chemical Industries Ltd....
BioCentury | Jul 23, 2010
Company News

'Positive outcome' for pitavastatin

...the reference member state. The product is expected to be launched next year. Kowa and Nissan Chemical Industries Ltd....
BioCentury | Jul 5, 2010
Company News

Abbott, Kowa sales and marketing update

...treat primary hyperlipidemia or mixed dyslipidemia. The HMG-CoA reductase inhibitor was co-developed by Kowa and Nissan Chemical Industries Ltd....
BioCentury | May 3, 2010
Clinical News

Livalo pitavastatin: Extension study data

...primary hypercholesterolemia and combined dyslipidemia and will be launched in June. Livalo was co-developed with Nissan Chemical Industries Ltd....
BioCentury | Sep 7, 2009
Clinical News

Livalo pitavastatin: Phase III data

...to treat primary hypercholesterolemia and combined dyslipidemia (see BioCentury, Aug. 10). Livalo was co-developed with Nissan Chemical Industries Ltd....
BioCentury | Sep 7, 2009
Clinical News

Livalo pitavastatin: Phase III data

...to treat primary hypercholesterolemia and combined dyslipidemia (see BioCentury, Aug. 10). Livalo was co-developed with Nissan Chemical Industries Ltd....
BioCentury | Sep 7, 2009
Clinical News

Livalo pitavastatin: Phase I data

...is under review in 16 European countries under the decentralized procedure. Livalo was co-developed with Nissan Chemical Industries Ltd....
BioCentury | Aug 10, 2009
Clinical News

Livalo pitavastatin regulatory update

...to launch the HMG-CoA reductase inhibitor in the U.S. in 1Q10. Livalo was co-developed with Nissan Chemical Industries Ltd....
Items per page:
1 - 10 of 27
BioCentury | Feb 15, 2016
Company News

Shionogi, Nissan Chemical deal

...toxicity. The companies did not respond to inquiries. Shionogi & Co. Ltd. (Tokyo:4507), Osaka, Japan Nissan Chemical Industries Ltd....
BioCentury | Aug 23, 2010
Clinical News

Livalo pitavastatin regulatory update

...reference member state. Kowa said pitavastatin has also been approved in the Netherlands. Kowa and Nissan Chemical Industries Ltd....
BioCentury | Jul 26, 2010
Clinical News

Livalo pitavastatin regulatory update

...the reference member state. The product is expected to be launched next year. Kowa and Nissan Chemical Industries Ltd....
BioCentury | Jul 23, 2010
Company News

'Positive outcome' for pitavastatin

...the reference member state. The product is expected to be launched next year. Kowa and Nissan Chemical Industries Ltd....
BioCentury | Jul 5, 2010
Company News

Abbott, Kowa sales and marketing update

...treat primary hyperlipidemia or mixed dyslipidemia. The HMG-CoA reductase inhibitor was co-developed by Kowa and Nissan Chemical Industries Ltd....
BioCentury | May 3, 2010
Clinical News

Livalo pitavastatin: Extension study data

...primary hypercholesterolemia and combined dyslipidemia and will be launched in June. Livalo was co-developed with Nissan Chemical Industries Ltd....
BioCentury | Sep 7, 2009
Clinical News

Livalo pitavastatin: Phase III data

...to treat primary hypercholesterolemia and combined dyslipidemia (see BioCentury, Aug. 10). Livalo was co-developed with Nissan Chemical Industries Ltd....
BioCentury | Sep 7, 2009
Clinical News

Livalo pitavastatin: Phase III data

...to treat primary hypercholesterolemia and combined dyslipidemia (see BioCentury, Aug. 10). Livalo was co-developed with Nissan Chemical Industries Ltd....
BioCentury | Sep 7, 2009
Clinical News

Livalo pitavastatin: Phase I data

...is under review in 16 European countries under the decentralized procedure. Livalo was co-developed with Nissan Chemical Industries Ltd....
BioCentury | Aug 10, 2009
Clinical News

Livalo pitavastatin regulatory update

...to launch the HMG-CoA reductase inhibitor in the U.S. in 1Q10. Livalo was co-developed with Nissan Chemical Industries Ltd....
Items per page:
1 - 10 of 27